rs147653673

Variant summary

Our verdict is Benign. The variant received -11 ACMG points: 2P and 13B. PM1BP4_StrongBP6BS1BS2

The NM_006907.4(PYCR1):​c.334C>T​(p.Arg112Trp) variant causes a missense change. The variant allele was found at a frequency of 0.00152 in 1,607,872 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R112Q) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00098 ( 1 hom., cov: 33)
Exomes 𝑓: 0.0016 ( 4 hom. )

Consequence

PYCR1
NM_006907.4 missense

Scores

6
13

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:4

Conservation

PhyloP100: 6.14

Publications

7 publications found
Variant links:
Genes affected
PYCR1 (HGNC:9721): (pyrroline-5-carboxylate reductase 1) This gene encodes an enzyme that catalyzes the NAD(P)H-dependent conversion of pyrroline-5-carboxylate to proline. This enzyme may also play a physiologic role in the generation of NADP(+) in some cell types. The protein forms a homopolymer and localizes to the mitochondrion. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2013]
PYCR1 Gene-Disease associations (from GenCC):
  • autosomal recessive cutis laxa type 2B
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, PanelApp Australia, Orphanet, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), ClinGen
  • PYCR1-related de Barsy syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, G2P, Ambry Genetics, PanelApp Australia
  • geroderma osteodysplastica
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -11 ACMG points.

PM1
In a hotspot region, there are 4 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 2 benign, 3 uncertain in NM_006907.4
BP4
Computational evidence support a benign effect (MetaRNN=0.024432719).
BP6
Variant 17-81935132-G-A is Benign according to our data. Variant chr17-81935132-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 282265.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.000978 (149/152306) while in subpopulation SAS AF = 0.00248 (12/4830). AF 95% confidence interval is 0.00151. There are 1 homozygotes in GnomAd4. There are 74 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 4 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PYCR1NM_006907.4 linkc.334C>T p.Arg112Trp missense_variant Exon 4 of 7 ENST00000329875.13 NP_008838.2 P32322-1A0A024R8U9Q8TBX0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PYCR1ENST00000329875.13 linkc.334C>T p.Arg112Trp missense_variant Exon 4 of 7 1 NM_006907.4 ENSP00000328858.8 P32322-1

Frequencies

GnomAD3 genomes
AF:
0.000979
AC:
149
AN:
152188
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000386
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00248
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00176
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000832
AC:
203
AN:
244016
AF XY:
0.000895
show subpopulations
Gnomad AFR exome
AF:
0.000316
Gnomad AMR exome
AF:
0.000233
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000330
Gnomad NFE exome
AF:
0.00144
Gnomad OTH exome
AF:
0.000333
GnomAD4 exome
AF:
0.00157
AC:
2287
AN:
1455566
Hom.:
4
Cov.:
33
AF XY:
0.00155
AC XY:
1126
AN XY:
724264
show subpopulations
African (AFR)
AF:
0.000239
AC:
8
AN:
33440
American (AMR)
AF:
0.000134
AC:
6
AN:
44642
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26122
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39686
South Asian (SAS)
AF:
0.000824
AC:
71
AN:
86140
European-Finnish (FIN)
AF:
0.000207
AC:
10
AN:
48256
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5316
European-Non Finnish (NFE)
AF:
0.00193
AC:
2150
AN:
1111710
Other (OTH)
AF:
0.000697
AC:
42
AN:
60254
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
150
301
451
602
752
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
86
172
258
344
430
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000978
AC:
149
AN:
152306
Hom.:
1
Cov.:
33
AF XY:
0.000994
AC XY:
74
AN XY:
74482
show subpopulations
African (AFR)
AF:
0.000385
AC:
16
AN:
41566
American (AMR)
AF:
0.0000653
AC:
1
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.00248
AC:
12
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00176
AC:
120
AN:
68002
Other (OTH)
AF:
0.00
AC:
0
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.518
Heterozygous variant carriers
0
8
16
23
31
39
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00125
Hom.:
0
Bravo
AF:
0.000756
TwinsUK
AF:
0.000809
AC:
3
ALSPAC
AF:
0.00234
AC:
9
ESP6500AA
AF:
0.000681
AC:
3
ESP6500EA
AF:
0.00128
AC:
11
ExAC
AF:
0.000850
AC:
103
Asia WGS
AF:
0.000866
AC:
3
AN:
3478
EpiCase
AF:
0.00104
EpiControl
AF:
0.00137

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:4
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:3
Jul 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PYCR1: BP4 -

Sep 11, 2015
Eurofins Ntd Llc (ga)
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 20, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cutis laxa Uncertain:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -

Autosomal recessive cutis laxa type 2B;C3280799:PYCR1-related de Barsy syndrome Uncertain:1
Oct 31, 2018
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

PYCR1-related disorder Benign:1
Jul 03, 2024
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.34
T
BayesDel_noAF
Benign
-0.26
CADD
Pathogenic
27
DANN
Uncertain
1.0
DEOGEN2
Benign
0.25
T;.;.;.;T;.;T;.;T;T;T;.;T;T;T
Eigen
Benign
-0.026
Eigen_PC
Benign
-0.077
FATHMM_MKL
Uncertain
0.84
D
LIST_S2
Uncertain
0.96
.;D;D;D;D;.;D;D;D;D;D;D;D;D;D
M_CAP
Uncertain
0.15
D
MetaRNN
Benign
0.024
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.92
T
MutationAssessor
Benign
1.6
L;L;.;.;L;.;.;.;.;.;.;.;.;.;.
PhyloP100
6.1
PrimateAI
Benign
0.24
T
PROVEAN
Benign
-1.3
N;N;N;.;.;.;.;N;.;.;.;.;.;.;.
REVEL
Benign
0.21
Sift
Uncertain
0.027
D;D;D;.;.;.;.;T;.;.;.;.;.;.;.
Sift4G
Uncertain
0.031
D;D;D;T;D;T;T;D;.;D;.;.;T;.;.
Polyphen
0.96
D;.;.;.;D;.;.;.;.;.;.;.;.;.;.
Vest4
0.45
MVP
0.78
MPC
0.18
ClinPred
0.084
T
GERP RS
4.1
Varity_R
0.12
gMVP
0.63
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs147653673; hg19: chr17-79893008; COSMIC: COSV57999298; COSMIC: COSV57999298; API